On Aug. 15, 2014, plaintiff’s decedent Suneet “Sonia” Kaur Nijjar, a pediatric dental resident in a program at the University of Southern California, was given ketorolac, which is a non-steroidal anti-inflammatory drug (NSAID), at Ronald Reagan UCLA Medical Center, in Los Angeles. Nijjar was suffering from a diffuse rash, diarrhea, and a fever, which began after eating oysters. After being treated for two weeks at Marina Del Rey Hospital, in Los Angeles, she was transferred to Ronald Reagan UCLA Medical Center on July 25, 2014. She was subsequently evaluated by specialists at Ronald Reagan UCLA Medical Center, and she was diagnosed with a drug rash/reaction with eosinophilia and systemic symptoms (DRESS syndrome), which is a reaction caused by exposure to certain medications. It was unknown at that time what medication(s) triggered the DRESS syndrome. On Aug. 15, 2014, Nijjar complained of pain and was given an injection of ketorolac. She subsequently developed a severe rash, and quickly deteriorated. A skin biopsy found toxic epidermal necrolysis (TEN). As a result, Nijjar was transferred to the burn center at UC Irvine Medical Center, in Orange, but she died 13 days later, on Aug. 28, 2014. Nijjar’s husband, Harpreet Singh Everest, sued the operator of Ronald Reagan UCLA Medical Center, the Regents of the University of California. Plaintiff’s counsel contended that NSAIDs are known to cause TEN and that Regents, through its employees, administered one or more doses of ketorolac while Nijjar was a patient. Counsel asserted that at the time the Regent’s employees administered ketorolac to Nijjar, the drug had been contraindicated by Nijjar’s physician at Ronald Reagan UCLA Medical Center because Nijjar had previously suffered multiple reactions to NSAIDs. Plaintiff’s counsel contended that Nijjar’s multiple reactions to NSAIDs were noted in her records by a Regent’s employee, and asserted that when a drug is contraindicated for a patient, it must never be administered to that patient. Counsel contended that as a result, prior to the administration ketorolac to Nijjar, a Regent’s employee contraindicated all NSAIDs for her and noted the same in her chart by placing ketorolac on Nijjar’s allergy list. Thus, plaintiff’s counsel asserted that the Regents staff knew that under no circumstances should Nijjar ever be administered any NSAID and that the administration of one or more doses of the contraindicated ketorolac by a Regent’s employee caused Nijjar’s untimely death. The Regents of the University of California ultimately admitted liability two months before trial., Nijjar suffered from toxic epidermal necrolysis (TEN), which was caused by exposure to the drug ketorolac. She was subsequently transferred to the burn center at UC Irvine Medical Center, but she ultimately died as a result of the effects of TEN on Aug. 28, 2014. Nijjar was survived by her husband, Everest, whom she met when they were both 18 years old and in college. Nijjar was attending the University of California, Berkeley, and Everest was attending the University of California, Davis. Upon graduation from college, they both attended dental school at the University of Southern California, and both graduated with their doctorate degree in dentistry. Nijjar and Everest eventually married on Aug. 31, 2013, approximately one year before Nijjar’s death. At the time of her death, Nijjar was 29 years old and one of eight residents in the two-year pediatric dental residency program at the University of Southern California. Nijjar had allegedly planned to help children in pediatric dentistry, and share her life with her husband. Thus, Nijjar’s husband, Everest, sought recovery of wrongful death damages for the loss of Nijjar. The plaintiff’s vocational rehabilitation expert opined that the future loss of Nijjar’s wages was approximately $187,000 per year. However, the amount was disputed by defense counsel since Nijjar had not completed the pediatric dental residency program.